CL2008000931A1 - Cross-linked oral vaccine solids containing a pharmaceutically active ingredient, a bioadhesive, an oligasacaride, a mediator mixture comprising an emulsifier and one or more monosaccharides and / or disacarids; method for its preparation; use of solida oral vaccine particle. - Google Patents

Cross-linked oral vaccine solids containing a pharmaceutically active ingredient, a bioadhesive, an oligasacaride, a mediator mixture comprising an emulsifier and one or more monosaccharides and / or disacarids; method for its preparation; use of solida oral vaccine particle.

Info

Publication number
CL2008000931A1
CL2008000931A1 CL2008000931A CL2008000931A CL2008000931A1 CL 2008000931 A1 CL2008000931 A1 CL 2008000931A1 CL 2008000931 A CL2008000931 A CL 2008000931A CL 2008000931 A CL2008000931 A CL 2008000931A CL 2008000931 A1 CL2008000931 A1 CL 2008000931A1
Authority
CL
Chile
Prior art keywords
oral vaccine
active ingredient
pharmaceutically active
bioadhesive
oligasacaride
Prior art date
Application number
CL2008000931A
Other languages
Spanish (es)
Inventor
Harel Moti
Original Assignee
Advanced Bionutrition Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=51399071&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CL2008000931(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Advanced Bionutrition Corp filed Critical Advanced Bionutrition Corp
Priority to CL2008000931A priority Critical patent/CL2008000931A1/en
Publication of CL2008000931A1 publication Critical patent/CL2008000931A1/en

Links

Abstract

Composición para la administración oral a un animal para la liberación intestinal de un ingrediente farmacéuticamente activo que comprende al menos un polímero bioadhesivo, al menos un oligosacárido y al menos un compuesto mediador; uso de la composición para preparar una vacuna oral para un animal.Composition for oral administration to an animal for intestinal release of a pharmaceutically active ingredient comprising at least one bioadhesive polymer, at least one oligosaccharide and at least one mediator compound; use of the composition to prepare an oral vaccine for an animal.

CL2008000931A 2008-03-31 2008-03-31 Cross-linked oral vaccine solids containing a pharmaceutically active ingredient, a bioadhesive, an oligasacaride, a mediator mixture comprising an emulsifier and one or more monosaccharides and / or disacarids; method for its preparation; use of solida oral vaccine particle. CL2008000931A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CL2008000931A CL2008000931A1 (en) 2008-03-31 2008-03-31 Cross-linked oral vaccine solids containing a pharmaceutically active ingredient, a bioadhesive, an oligasacaride, a mediator mixture comprising an emulsifier and one or more monosaccharides and / or disacarids; method for its preparation; use of solida oral vaccine particle.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CL2008000931A CL2008000931A1 (en) 2008-03-31 2008-03-31 Cross-linked oral vaccine solids containing a pharmaceutically active ingredient, a bioadhesive, an oligasacaride, a mediator mixture comprising an emulsifier and one or more monosaccharides and / or disacarids; method for its preparation; use of solida oral vaccine particle.

Publications (1)

Publication Number Publication Date
CL2008000931A1 true CL2008000931A1 (en) 2008-11-07

Family

ID=51399071

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2008000931A CL2008000931A1 (en) 2008-03-31 2008-03-31 Cross-linked oral vaccine solids containing a pharmaceutically active ingredient, a bioadhesive, an oligasacaride, a mediator mixture comprising an emulsifier and one or more monosaccharides and / or disacarids; method for its preparation; use of solida oral vaccine particle.

Country Status (1)

Country Link
CL (1) CL2008000931A1 (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9623094B2 (en) 2009-03-27 2017-04-18 Advanced Bionutrition Corporation Microparticulated vaccines for the oral or nasal vaccination and boostering of animals including fish
US9737578B2 (en) 2005-12-28 2017-08-22 Advanced Bionutrition Corp. Delivery vehicle for probiotic bacteria comprising a dry matrix of polysaccharides, saccharides and polyols in a glass form and methods of making same
US10206421B2 (en) 2010-01-28 2019-02-19 Advanced Bionutrition Corp. Stabilizing composition for biological materials
US10953050B2 (en) 2015-07-29 2021-03-23 Advanced Bionutrition Corp. Stable dry probiotic compositions for special dietary uses

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9737578B2 (en) 2005-12-28 2017-08-22 Advanced Bionutrition Corp. Delivery vehicle for probiotic bacteria comprising a dry matrix of polysaccharides, saccharides and polyols in a glass form and methods of making same
US9623094B2 (en) 2009-03-27 2017-04-18 Advanced Bionutrition Corporation Microparticulated vaccines for the oral or nasal vaccination and boostering of animals including fish
US10206421B2 (en) 2010-01-28 2019-02-19 Advanced Bionutrition Corp. Stabilizing composition for biological materials
US10953050B2 (en) 2015-07-29 2021-03-23 Advanced Bionutrition Corp. Stable dry probiotic compositions for special dietary uses

Similar Documents

Publication Publication Date Title
CL2009001766A1 (en) Solid pharmaceutical composition for oral administration comprising: a defined substantially amorphous taxane, a defined hydrophilic carrier and a defined surfactant; method of preparing the composition; and its use to treat neoplastic disease.
GT201000095A (en) SOLID DISPERSION PRODUCT CONTAINING A N-ARIL UREA-BASED COMPOUND
CL2013001586A1 (en) Rapid dispersion microgranular composition comprising at least one sugar alcohol, a saccharide, or a mixture thereof, at least one super disintegrant and at least one multifunctional additive; oral disintegration tablet comprising the microgranular composition and at least one active ingredient; and manufacturing methods.
CL2007002018A1 (en) COMPOUNDS DERIVED FROM SUBSTITUTED ISOXAZOLINS; PREPARATION PROCEDURE; PHARMACEUTICAL COMPOSITION; AND USE OF THE COMPOUND FOR THE TREATMENT OF A DISEASE CAUSED BY AN INCREASE IN THE CELL PROLIFERATION.
PE20142192A1 (en) PHARMACEUTICAL DOSAGE FORM INCLUDING NIFEDIPINE OR NISOLDIPINE AND AN ANGIOTENSIN II ANTAGONIST AND / OR DIURETIC
SV2009002857A (en) SOLID PHARMACEUTICAL PRESENTATION FORMS OF ORAL ADMINISTRATION WITH QUICK RELEASE OF ACTIVE PRINCIPLE
AR060755A1 (en) FORMULATIONS OF DIPEPTIDIL PEPTIDASA IV INHIBITORS (DPP IV)
BRPI0814666A2 (en) pharmaceutical composition for oral administration, use of a formulation. process for preparing a solid dosage form, and, solid dosage form
BR112017008993A2 (en) Methods and Compositions Specifically for the Treatment of Attention Deficit Disorder
BRPI1007945B8 (en) pharmaceutical formulation of controlled release of nitazoxamide, tizoxanide or a combination thereof, and bilayer tablet for oral administration
CL2011000558A1 (en) Crystalline forms of a compound derived from 2-thiazolyl-4-quinolinyl-oxy; Sodium salt of the compound, pharmaceutical composition comprising sodium salt, useful for treating hepatitis C virus infection.
AR047993A1 (en) PHARMACEUTICAL COMPOSITION THAT PIMOBENDAN INCLUDES
CL2011002858A1 (en) Use of an oral transmucosal pharmaceutical composition comprising dexmedetomidine and a pharmaceutically acceptable salt and a pharmaceutically acceptable excipient to prepare a medicament useful for treating or preventing pain.
CL2007001917A1 (en) COMPOUNDS DERIVED FROM SIPROCICLIC AZAINDOL; PREPARATION PROCEDURE; PHARMACEUTICAL COMPOSITION; AND USE FOR THE TREATMENT OF PAIN, CONDITIONS OF PANIC, DEPRESSION, EVIL OF ALZHEIMER, MIGRANA, AMONG OTHERS.
NO20074933L (en) Pharmaceutical composition comprising an indolylmaleimide derivative
ECSP10010588A (en) FORMULATION OF SOLID DRUG WITH DELAYED RELEASE
IL195269A0 (en) Pharmaceutical formulations for the sustained release of active ingredient(s), as well as their applications, especially therapeutic
BRPI0807285A2 (en) "COMPOSITION, METHOD FOR PREPARING PHARMACEUTICAL COMPOSITION, UNIT FORM OF DOSAGE, METHOD FOR ADMINISTRATING A BIOLOGICAL ACTIVE AGENT NEEDING THE AGENT, METHOD FOR INCREASING BIODISPONABILITY FOR PREPARING AN AGENT OF COMPOSITION"
BR112012003280A2 (en) pharmaceutical composition for oral administration, method for treating a disease, use of the compound, and, compound.
NO20082047L (en) Slow release composition, process for its preparation and use thereof
WO2007025182A3 (en) Drug compositions containing controlled release hypromellose matrices
NZ597317A (en) Solid pharmaceutical fixed dose compositions comprising irbesartan and amlodipine, their preparation and their therapeutic application
TN2015000135A1 (en) Modified release formulations for oprozomib
BRPI0810025A2 (en) ORAL PHARMACEUTICAL FORMULATION FOR IMMEDIATE RELEASE, METHOD FOR PREPARING A MULTIPARTICULATED PHARMACEUTICAL FORMULATION, AND USE OF URSODESOXICOLIC ACID
CL2008000931A1 (en) Cross-linked oral vaccine solids containing a pharmaceutically active ingredient, a bioadhesive, an oligasacaride, a mediator mixture comprising an emulsifier and one or more monosaccharides and / or disacarids; method for its preparation; use of solida oral vaccine particle.